India, Nov. 19 -- image credit- freepik

The Ministry of Health and Family Welfare has issued a draft gazette notification proposing amendments to the New Drugs and Clinical Trials Rules, 2019. Under this, 'antimicrobials' (antimicrobial drugs) will be included in the 'new drug' as defined in Rule 2(1)(w)(v).

Antimicrobial resistance (AMR) is a major concern for global public health and is a priority issue that requires coordinated action to address. The G-20 New Delhi Leaders' Declaration also emphasised the need to tackle the problem of antimicrobial resistance through a 'One Health' approach.

This proposed amendment has been initiated in response to concerns related to the issuance of manufacturing licenses for antimicrobial products...